13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-07-20 Event 2026-07-16 SEC 0000921895-26-001834 →

Velan Capital Investment Management LP Jasper Therapeutics, Inc. JSPRW

Stake: Shares: 3,021,915 Class: Voting Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 1.00
11,693 shares short · -19.9% vs prior

Other 13D/G Filings on Jasper Therapeutics, Inc.

FiledFormFilerStakeShares
2026-08-17 SCHEDULE 13G Velan Capital Investment Management LP view →

Other Filings by Velan Capital Investment Management LP

FiledFormIssuerStakeShares
2026-08-25 SCHEDULE 13D/A Edesa Biotech, Inc. 1,081,385 view →
2026-08-17 SCHEDULE 13G Jasper Therapeutics, Inc. view →
2024-05-16 SC ALIMERA SCIENCES INC view →
2022-07-12 SC Radius Health, Inc. view →
2022-05-25 SC Radius Health, Inc. view →
2022-03-15 SC Radius Health, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →